|
NPEPPS expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.34336985979644E-14 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.65789999506671E-08 |
| Normal-vs-Stage2 |
2.087900E-02 |
| Normal-vs-Stage3 |
5.026200E-02 |
| Normal-vs-Stage4 |
1.587240E-01 |
| Stage1-vs-Stage2 |
4.425000E-01 |
| Stage1-vs-Stage3 |
3.129800E-01 |
| Stage1-vs-Stage4 |
5.830400E-01 |
| Stage2-vs-Stage3 |
2.481200E-01 |
| Stage2-vs-Stage4 |
4.201200E-01 |
| Stage3-vs-Stage4 |
9.161600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.65283367390157E-12 |
| Normal-vs-AfricanAmerican |
4.037000E-04 |
| Normal-vs-Asian |
2.029400E-01 |
| Caucasian-vs-AfricanAmerican |
5.149400E-01 |
| Caucasian-vs-Asian |
8.389000E-01 |
| AfricanAmerican-vs-Asian |
9.794200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.49510453701419E-11 |
| Normal-vs-Female |
3.05759999541522E-08 |
| Male-vs-Female |
4.636100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.180300E-03 |
| Normal-vs-Extreme_Weight |
1.035550E-04 |
| Normal-vs-Obese |
2.28409999999402E-05 |
| Normal-vs-Extreme_Obese |
2.241600E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.535000E-01 |
| Normal_Weight-vs-Obese |
3.149400E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.628800E-01 |
| Extreme_Weight-vs-Obese |
4.385400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.005800E-01 |
| Obese-vs-Extreme_Obese |
6.139800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.79780999999268E-05 |
| Normal-vs-Age(41-60Yrs) |
2.95696800378664E-12 |
| Normal-vs-Age(61-80Yrs) |
3.72240000001689E-06 |
| Normal-vs-Age(81-100Yrs) |
8.900200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.348800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.284260E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.262600E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.981900E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.406300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.631840E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.33066907387547E-16 |
| Normal-VS-Type2 PRCC |
1.520600E-01 |
| Normal-VS-KIRP CIMP |
1.287890E-02 |
| Normal-VS-Unclassified PRCC |
2.538800E-03 |
| Type1 PRCC-VS-Type2 PRCC |
4.99389999997213E-06 |
| Type1 PRCC-VS-KIRP CIMP |
4.306600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.334600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.155700E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
2.335900E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
5.608200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.740900E-03 |
| Normal-vs-N1 |
2.426100E-02 |
| Normal-vs-N2 |
3.134000E-01 |
| N0-vs-N1 |
5.443000E-01 |
| N0-vs-N2 |
7.015600E-01 |
| N1-vs-N2 |
9.578600E-01 |
|
|
